Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1971 1
1973 1
1977 1
1978 2
1979 3
1980 2
1981 1
1982 1
1983 2
1984 2
1986 3
1987 4
1988 1
1989 2
1990 1
1991 3
1992 3
1993 5
1994 4
1995 6
1996 5
1997 3
1998 11
1999 7
2000 5
2001 9
2002 6
2003 6
2004 1
2005 5
2006 5
2007 9
2008 7
2009 5
2010 8
2011 7
2012 7
2013 13
2014 7
2015 2
2016 7
2017 8
2018 3
2019 6
2020 7
2021 6
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Vitamin D Supplementation and Prevention of Type 2 Diabetes.
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, O'Neil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M; D2d Research Group. Pittas AG, et al. Among authors: foreyt j. N Engl J Med. 2019 Aug 8;381(6):520-530. doi: 10.1056/NEJMoa1900906. Epub 2019 Jun 7. N Engl J Med. 2019. PMID: 31173679 Free PMC article. Clinical Trial.
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
Look AHEAD Research Group; Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ. Look AHEAD Research Group, et al. Among authors: foreyt jp. N Engl J Med. 2013 Jul 11;369(2):145-54. doi: 10.1056/NEJMoa1212914. Epub 2013 Jun 24. N Engl J Med. 2013. PMID: 23796131 Free PMC article. Clinical Trial.
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.
Look AHEAD Research Group; Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, Foreyt J, Foster G, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ. Look AHEAD Research Group, et al. Among authors: foreyt j. Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. doi: 10.1016/S2213-8587(16)30162-0. Epub 2016 Aug 30. Lancet Diabetes Endocrinol. 2016. PMID: 27595918 Free PMC article. Clinical Trial.
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.
Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, Perri MG, Pi-Sunyer FX, Rock CL, Erickson JS, Maier HN, Kim DD, Dunayevich E. Wadden TA, et al. Among authors: foreyt jp. Obesity (Silver Spring). 2011 Jan;19(1):110-20. doi: 10.1038/oby.2010.147. Epub 2010 Jun 17. Obesity (Silver Spring). 2011. PMID: 20559296 Free PMC article. Clinical Trial.
Eating disorders: A 25-year perspective.
Andersen A, Foreyt J, Maine M, Cohn L. Andersen A, et al. Among authors: foreyt j. Eat Disord. 2017 Oct-Dec;25(5):436-447. doi: 10.1080/10640266.2017.1368874. Eat Disord. 2017. PMID: 29106343
Weight-reducing diets: are there any differences?
Foreyt JP, Salas-Salvado J, Caballero B, Bulló M, Gifford KD, Bautista I, Serra-Majem L. Foreyt JP, et al. Nutr Rev. 2009 May;67 Suppl 1:S99-101. doi: 10.1111/j.1753-4887.2009.00169.x. Nutr Rev. 2009. PMID: 19453689 Review.
The Issue of Aversion in Lifestyle Treatments.
Arlinghaus KR, Foreyt JP, Johnston CA. Arlinghaus KR, et al. Among authors: foreyt jp. Am J Lifestyle Med. 2016 Dec 16;11(2):119-121. doi: 10.1177/1559827616680554. eCollection 2017 Mar-Apr. Am J Lifestyle Med. 2016. PMID: 30202321 Free PMC article. Review.
Sibutramine and the management of obesity.
Poston WS, Foreyt JP. Poston WS, et al. Among authors: foreyt jp. Expert Opin Pharmacother. 2004 Mar;5(3):633-42. doi: 10.1517/14656566.5.3.633. Expert Opin Pharmacother. 2004. PMID: 15013931 Review.
Obesity is an environmental issue.
Poston WS 2nd, Foreyt JP. Poston WS 2nd, et al. Among authors: foreyt jp. Atherosclerosis. 1999 Oct;146(2):201-9. doi: 10.1016/s0021-9150(99)00258-0. Atherosclerosis. 1999. PMID: 10532676 Review.
199 results